Our customers' Feedback
Search:
Perform search
Categories list

Generic Pristiq

News
Pristiq
Pristiq photo

Generic Pristiq (Desvenlafaxine)

Antidepressants

PackagePricePer PillSavingsOrder
50mg × 10 pills$17.95$1.79Add to cart
50mg × 20 pills$29.95$1.50$5.95Add to cart
50mg × 30 pills$39.95$1.33$13.90Add to cart
50mg × 60 pills$64.95$1.08$42.75Add to cart
50mg × 90 pills$89.95$1.00$71.60Add to cart

PackagePricePer PillSavingsOrder
100mg × 10 pills$19.95$1.99Add to cart
100mg × 20 pills$34.95$1.75$4.95Add to cart
100mg × 30 pills$49.95$1.67$9.90Add to cart
100mg × 60 pills$89.95$1.50$29.75Add to cart
100mg × 90 pills$129.95$1.44$49.60Add to cart

Most popular quantity.
Savella
$ 0.78
Generic Savella
(Milnacipran 50mg)
Sinequan
$ 0.56
Generic Sinequan
(Doxepin 10/25/75mg)
Tofranil
$ 0.56
Generic Tofranil
(Imipramine 25/75mg)
Wellbutrin Sr
$ 1.00
Generic Wellbutrin Sr
(Bupropion 150mg)
Anafranil
$ 0.72
Generic Anafranil
(Clomipramine 10/25/50mg)
Aventyl
$ 0.97
Generic Aventyl
(Nortriptyline 25mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Can Supplements Help Fight Depression? - Men's Journal

    Men's JournalCan Supplements Help Fight Depression?Men's JournalAccording to a new meta-analysis from the University of Melbourne in Australia, certain dietary supplements may increase the effectiveness of antidepressants such as Zoloft, Paxil, Pristiq, and Cymbalta.

  • Pfizer's (PFE) Phase 3 Study of Pristiq in MDD Misses Primary Endpoint - StreetInsider.com

    Pfizer's (PFE) Phase 3 Study of Pristiq in MDD Misses Primary EndpointStreetInsider.

  • Pfizer's Pristiq Fails Phase III Trial for Depression in Children - Genetic Engineering & Biotechnology News

    Wall Street JournalPfizer's Pristiq Fails Phase III Trial for Depression in ChildrenGenetic Engineering & Biotechnology NewsPfizer said its marketed antidepressant drug candidate Pristiq® (desvenlafaxine succinate sustained-release formulation) failed a Phase III clinical trial assessing the drug's effectiveness and safety for a new indication, major depressive disorder in .

  • Dialing Back Euphoria: The Intellipharmaceutics Prescription for Opioid Abuse - InvestorIdeas.com (press release)

    InvestorIdeas.

  • Intellipharmaceutics International Inc. (IPCI) Updated Broker Ratings - Risers & Fallers

    Intellipharmaceutics International Inc.

    Copyright © cheapgenerics24.com